YPL162C Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Protein

YPL162C is a gene encoding a vacuolar membrane protein in S. cerevisiae, annotated as a multi-pass transmembrane protein localized to the vacuole membrane . The antibody (UniProt ID: Q12042) binds specifically to this protein, enabling its detection in assays such as Western blotting (WB), immunofluorescence (IF), and immunoprecipitation (IP) .

PropertyDetail
Target NameYPL162C
UniProt IDQ12042
Species ReactivitySaccharomyces cerevisiae (strain ATCC 204508 / S288c)
Subcellular LocalizationVacuole membrane
ApplicationsWB, IF, IP

Functional Insights

YPL162C is implicated in vacuolar function, though its precise role remains under investigation. Studies suggest involvement in stress response pathways, particularly the unfolded protein response (UPR). For example, ribosome ubiquitination during UPR has been linked to translational regulation of stress-response genes, though direct evidence for YPL162C’s role in this process is limited .

Key Studies

  • Translational Regulation: A 2020 bioRxiv study identified YPL162C in screens for genes affected by ribosomal protein ubiquitination during ER stress. The eS7A-4KR mutant (a ribosome-associated protein) showed diminished downregulation of HNT1 mRNA, hinting at broader regulatory networks involving vacuolar proteins .

  • Antibody Validation: The YPL162C antibody has been used to confirm protein expression levels in yeast strains under varying stress conditions .

Broader Context in Antibody Development

Monoclonal and polyclonal antibodies like YPL162C are critical tools for studying yeast cell biology. Advances in phage display and recombinant protein expression have enhanced antibody specificity and affinity, enabling precise target detection . The YPL162C antibody exemplifies these advancements, offering researchers a reliable reagent for probing vacuolar membrane dynamics .

Future Directions

Further studies are needed to clarify YPL162C’s role in organelle biogenesis and stress adaptation. Coupling the antibody with CRISPR-edited yeast strains or proteomic approaches could unravel its interactome and regulatory mechanisms .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YPL162C; Vacuolar membrane protein YPL162C
Target Names
YPL162C
Uniprot No.

Target Background

Database Links

KEGG: sce:YPL162C

STRING: 4932.YPL162C

Subcellular Location
Vacuole membrane; Multi-pass membrane protein.

Q&A

What is YPL162C and what cellular functions does it perform?

YPL162C encodes a vacuolar membrane protein in Saccharomyces cerevisiae (baker's yeast), specifically characterized as a multi-pass transmembrane protein localized to the vacuole membrane. While its precise role remains under active investigation, research indicates potential involvement in stress response pathways, particularly the unfolded protein response (UPR). Studies suggest a connection between YPL162C and translational regulation during ER stress, as it has been identified in screens for genes affected by ribosomal protein ubiquitination.

What experimental applications are validated for commercial YPL162C antibodies?

Commercial YPL162C antibodies have been validated for multiple experimental applications:

ApplicationDescriptionTechnical Considerations
Western Blotting (WB)Protein expression quantificationTypically requires 20-50μg total protein per lane
Immunofluorescence (IF)Subcellular localization studiesOften used with vacuolar membrane markers for co-localization
Immunoprecipitation (IP)Protein-protein interaction analysisCan identify interaction partners in stress conditions
ELISAQuantitative protein detectionEnables precise measurement of expression levels

These applications enable comprehensive investigation of YPL162C expression, localization, and interactions under various experimental conditions .

How is specificity of YPL162C antibodies validated in research settings?

Rigorous validation of YPL162C antibodies involves multiple complementary approaches:

  • Genetic validation: Testing antibody reactivity in wild-type versus YPL162C knockout strains

  • Peptide competition assays: Demonstrating blocked antibody binding when pre-incubated with immunizing peptide

  • Mass spectrometry confirmation: Identifying immunoprecipitated proteins to confirm correct target binding

  • Cross-reactivity assessment: Testing against related proteins to ensure specific recognition

  • Multiple detection methods: Confirming consistent target recognition across different applications (WB, IF, IP)

What are the optimal Western blotting conditions for detecting YPL162C protein?

Optimal Western blotting protocols for YPL162C detection should include:

  • Sample preparation:

    • Use specialized yeast lysis buffers containing protease inhibitors

    • Include appropriate detergents (0.5-1% Triton X-100) to solubilize membrane proteins

  • Electrophoresis and transfer:

    • 10-12% SDS-PAGE gels for optimal resolution

    • Wet transfer to PVDF membranes at lower voltage (30V) overnight for efficient transfer of membrane proteins

  • Antibody incubation:

    • Block with 5% non-fat milk or BSA in TBST for 1 hour

    • Primary antibody dilution: 1:1000-1:2000, incubated overnight at 4°C

    • Extensive washing (4-5 times) between antibody incubations

    • Secondary antibody: 1:5000 HRP-conjugated anti-rabbit IgG

  • Controls:

    • Include YPL162C knockout samples as negative controls

    • Use vacuolar membrane fraction as positive control

    • Include loading controls (e.g., GAPDH)

How should immunofluorescence experiments be designed to accurately localize YPL162C?

For accurate subcellular localization of YPL162C using immunofluorescence:

  • Cell preparation:

    • Create spheroplasts using zymolyase (100T, 5μg/ml) in sorbitol buffer

    • Fix with 4% paraformaldehyde for 15 minutes

    • Permeabilize with 0.1% Triton X-100 for 5 minutes

  • Antibody staining:

    • Block with 3% BSA in PBS for 30 minutes

    • Apply YPL162C primary antibody (1:200 dilution) for 2 hours or overnight

    • Use fluorophore-conjugated secondary antibodies (1:500)

    • Include DAPI for nuclear counterstaining

  • Critical controls:

    • Co-stain with established vacuolar membrane markers (e.g., FM4-64)

    • Include YPL162C knockout cells as negative controls

    • Perform peptide competition controls

  • Imaging considerations:

    • Use confocal microscopy for precise membrane localization

    • Acquire Z-stacks to properly visualize entire vacuolar structures

    • Apply appropriate deconvolution algorithms for membrane signal enhancement

What are the most effective approaches for studying YPL162C expression under stress conditions?

To effectively study YPL162C expression under stress conditions:

  • Stress induction protocols:

    • ER stress: DTT (2-5mM) or tunicamycin (1-5μg/ml) for 1-4 hours

    • Oxidative stress: H₂O₂ (0.5-2mM) for 30-60 minutes

    • Heat shock: 37-42°C for 15-60 minutes

    • Nutrient deprivation: Transfer to minimal media for 1-24 hours

  • Expression analysis methods:

    • Time-course Western blotting to track expression changes

    • qRT-PCR for transcriptional analysis

    • Fluorescence microscopy to monitor localization changes

  • Data analysis approaches:

    • Quantify band intensity relative to unstressed controls

    • Normalize to housekeeping proteins unaffected by stress

    • Perform statistical analysis across biological replicates

  • Advanced considerations:

    • Combine with phospho-specific antibodies to detect stress-induced post-translational modifications

    • Perform co-immunoprecipitation to identify stress-specific interaction partners

How can researchers study YPL162C's role in the unfolded protein response pathway?

To investigate YPL162C's involvement in unfolded protein response:

  • UPR induction and monitoring:

    • Induce UPR with tunicamycin (1-5μg/ml) or DTT (2mM)

    • Monitor canonical UPR markers (HAC1 splicing, KAR2 upregulation)

    • Track YPL162C protein levels via Western blotting during UPR

  • Integration with ribosomal studies:

    • Investigate relationship between YPL162C and ribosomal protein ubiquitination

    • Analyze translation efficiency of stress-response mRNAs in YPL162C mutants

    • Perform polysome profiling to assess translational impacts

  • Advanced techniques:

    • Chromatin immunoprecipitation to identify potential transcriptional roles

    • Ribosome profiling to assess translational regulation

    • CRISPR-edited yeast strains with tagged YPL162C to track real-time dynamics

    • Proteomics analysis of YPL162C interactome during normal vs. stress conditions

What techniques enable investigation of YPL162C post-translational modifications?

For studying post-translational modifications of YPL162C:

  • Phosphorylation analysis:

    • Phos-tag SDS-PAGE for mobility shift detection

    • Phospho-specific antibodies against predicted phosphorylation sites

    • Mass spectrometry following immunoprecipitation

    • Phosphatase treatment to confirm phosphorylation status

  • Ubiquitination studies:

    • Immunoprecipitation under denaturing conditions

    • Probing with anti-ubiquitin antibodies

    • Expression of His-tagged ubiquitin for pulldown experiments

  • Other modifications:

    • Glycosylation analysis using glycosidase treatments

    • SUMOylation detection via specialized antibodies

    • Acetylation analysis through acetylation-specific antibodies

  • Functional correlation:

    • Site-directed mutagenesis of modification sites

    • Phenotypic analysis of modification-deficient mutants

    • Stress response comparisons between wild-type and modification-deficient strains

How can researchers distinguish between YPL162C and potentially homologous proteins?

To ensure specificity when studying YPL162C:

  • Epitope mapping strategies:

    • Use peptide arrays to precisely map antibody binding sites

    • Develop antibodies against unique regions that don't exist in homologous proteins

    • Select antibodies that recognize non-conserved epitopes

  • Cross-reactivity testing:

    • Test antibodies against recombinant homologous proteins

    • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

    • Include controls lacking YPL162C but expressing homologs

  • Genetic approaches:

    • Create epitope-tagged versions of YPL162C and homologs

    • Use CRISPR-Cas9 to introduce specific mutations or tags

    • Employ knockout strains as negative controls

  • Computational analysis:

    • Perform sequence alignment to identify unique regions

    • Use structural modeling to predict antibody accessibility

    • Design primers/probes that specifically amplify YPL162C

What strategies resolve weak or absent YPL162C antibody signals in Western blotting?

When experiencing weak or absent signals:

  • Sample preparation optimization:

    • Ensure complete lysis of yeast cells (verify microscopically)

    • Use specialized membrane protein extraction buffers

    • Include protease inhibitor cocktails to prevent degradation

    • Avoid extended sample storage or multiple freeze-thaw cycles

  • Technical adjustments:

    • Increase protein loading (40-80μg per lane)

    • Optimize primary antibody concentration (try 1:500 or more concentrated)

    • Extend primary antibody incubation (overnight at 4°C)

    • Use enhanced chemiluminescence substrate with higher sensitivity

    • Increase exposure time incrementally

  • Signal enhancement techniques:

    • Try membrane protein enrichment through fractionation

    • Use signal amplification systems (biotin-streptavidin or tyramide)

    • Consider alternative detection methods (fluorescent secondary antibodies)

    • Try reducing SDS concentration in transfer buffer for membrane proteins

How can researchers reconcile conflicting results between different antibody detection methods?

To address discrepancies between detection methods:

  • Methodological differences analysis:

    • Compare epitope accessibility in different techniques

    • Assess denaturing conditions that may alter antibody recognition

    • Consider fixation effects on epitope structure

    • Evaluate whether secondary antibodies perform differently across methods

  • Validation approaches:

    • Perform epitope mapping to understand binding requirements

    • Use multiple antibodies targeting different regions of YPL162C

    • Include comprehensive positive and negative controls

    • Confirm results with orthogonal, non-antibody techniques

  • Systematic troubleshooting:

    • Change one variable at a time to identify specific issues

    • Document all experimental conditions in detail

    • Use standardized positive controls across all experiments

    • Perform side-by-side comparisons under identical conditions

What experimental approaches help distinguish between phosphorylated and non-phosphorylated forms of YPL162C?

To differentiate phosphorylation states:

  • Biochemical approaches:

    • Lambda phosphatase treatment to remove phosphate groups

    • Phos-tag SDS-PAGE for mobility shift detection

    • 2D gel electrophoresis to separate based on charge differences

    • Generate and validate phospho-specific antibodies

  • Mass spectrometry analysis:

    • Immunoprecipitate YPL162C and perform phospho-peptide enrichment

    • Use targeted MS approaches to quantify specific phosphorylation sites

    • Compare phosphorylation patterns across different conditions

  • Functional studies:

    • Create phosphomimetic (S/T→D/E) and phospho-null (S/T→A) mutants

    • Compare phenotypes between wild-type and phospho-mutants

    • Assess interaction profiles of different phospho-forms

  • Data interpretation considerations:

    • Phosphorylation can cause molecular weight shifts (typically 1-3 kDa)

    • Multiple phosphorylation sites may exist with different functional impacts

    • Phosphorylation status may change rapidly during sample processing

How can autoantibody approaches inform fundamental YPL162C research?

Autoantibody research methodologies can enhance YPL162C studies:

  • Epitope mapping applications:

    • Use phage-displayed peptide libraries to identify immunodominant epitopes

    • Apply peptide arrays with overlapping residues to map linear epitopes

    • Identify conformational epitopes using constrained peptide libraries

  • Structural insights:

    • Autoantibodies can be used to probe protein conformation

    • Competition assays can map binding domains and functional regions

    • Compare epitope recognition between different experimental conditions

  • Translational research potential:

    • Develop more specific antibodies based on epitope mapping data

    • Create structure-guided antibody engineering approaches

    • Establish standardized validation protocols for research antibodies

What are current limitations in YPL162C antibody research and future directions?

Current limitations and future directions include:

  • Technological limitations:

    • Limited epitope mapping data for commercial antibodies

    • Variable performance across different experimental conditions

    • Incomplete characterization of post-translational modifications

  • Emerging approaches:

    • Single-domain antibodies for improved access to membrane protein epitopes

    • CRISPR-engineered endogenous tagging for improved detection

    • Native mass spectrometry for intact protein complex analysis

    • Advanced imaging techniques for real-time protein dynamics

  • Future research priorities:

    • Comprehensive characterization of YPL162C interactome during stress response

    • High-resolution structural studies of YPL162C in membrane environment

    • Development of conformation-specific antibodies

    • Integration of antibody-based detection with functional genomics approaches

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.